Home › Atopic Dermatitis (Eczema) › Oregon
Atopic Dermatitis (Eczema) clinical trials in Oregon
5 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in Oregon.
Cities in Oregon
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, Portland
RecruitingPhase 3
6 Months – 11 Years · All sexes · Updated Nov 9, 2026 · NCT06311682A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
- Oregon Medical Research Center, Portland
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 6, 2026 · NCT07783425A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Portland
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07003425A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 3, Portland
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Aug 12, 2026 · NCT07037901Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7073, Gresham
RecruitingObservational study
Ages 12 and older · All sexes · Updated Mar 13, 2026 · NCT06988605From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.